Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04841434 |
|---|---|
| Brief Title: | A Phase I/II Study to Investigate the Use of VORAXAZE™ as Intended Intervention in Patients With CNSL (VALIDATE) |
| First Submitted : | April 8, 2021 |
| First Submitted that Met QC Criteria : | April 8, 2021 |
| First Posted : | April 12, 2021 |
| Last Update Submitted that Met QC Criteria : | July 18, 2022 |
| Last Update Posted : | July 19, 2022 |